Used for decades for patients that need long-term oral anticoagulation [28] Slow onset of action, narrow therapeutic window, genetically determined inter- and intrapatient variability, and multiple possible interactions with various foods and drugs [19]
Indirect mechanism of action by inhibiting the synthesis of coagulation factors [29]
Acenocoumarol
Sinthrome, Sintrom
Phenprocoumon
Falithrom, Marcoumar
DOACs
Rivaroxaban
Xarelto
Faster onset and offset of action vs. VKAs [28], lower bleeding risk vs. warfarin in younger patients but not in those >75 years [30] Much more expensive vs. VKAs, but lower resource consumption vs. cost of VKAs and the required therapeutic monitoring [19] Betrixaban is not indicated for treatment. It is used as a prophylactic agent for prevention of deep vein thrombosis and pulmonary embolism in adults hospitalized for an acute medical illness [21]
Abbreviations: COX: cyclooxygenase enzyme; VKAs: vitamin K antagonists; DOACs: direct oral anticoagulants. There are many other brand names for some of the medications.